Tania Estapé1,2* and Cosimo Pieri1,3
1Europa Uomo Board, Spain
2FEFOC Fundació, Barcelona, Spain
3Europa Uomo Italy, Milan, Italy
*Corresponding Author: Tania Estapé, Europa Uomo Board, FEFOC Fundació, Barcelona, Spain.
Received: July 22, 2022; Published: July 29, 2022
Cancer is a disease feared for its relationship with death and suffering. Historically, the first cures are recent and the human being still associates the disease with a fatal end. Recent advances in cancer treatment imply cures and lengthening of life, but it is necessary to achieve quality of life. In prostate cancer, prostatectomy implies loss of erection and urinary incontinence, which alters the patient's life, self-esteem and sexuality. In order to reduce these unfortunate consequences, the therapeutic option called active surveillance has appeared. This option, paradoxically, consists of not treating but monitoring the tumor with follow-up and tests. It is indicated for low-risk tumors and opens the door to a radical change in the lives of those affected. However, our ancestors tell us that if it is cancer, it is best to remove it as soon as possible. This generates high levels of anxiety and family pressure. It is necessary to get patients to make the right decision so as not to suffer avoidable consequences.
Keywords: Cancer; Taboo Disease; Surveillance
Citation: Tania Estapé and Cosimo Pieri. Active Surveillance in Prostate Cancer: When the Best Therapeutic Option is not to Treat". Acta Scientific Applied Physics 2.8 (2022): 28-31.
Copyright: © 2022 Tania Estapé and Cosimo Pieri. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.